Buyang Huanwu decoction promotes post-stroke white matter repair via TREM2-Dependent microglial phagocytosis and IGF1 secretion.

Researchers investigated whether a traditional Chinese herbal formula called Buyang Huanwu Decoction (BYHWD) could help repair damage to the brain's white matter after a stroke. White matter consists of nerve fibers that allow different parts of the brain to communicate, and damage to these areas is a major reason why stroke survivors experience lasting disabilities.

The study used mice that had experienced strokes similar to those in humans. Scientists gave some mice BYHWD and compared their recovery to mice that didn't receive the treatment. They used various testing methods including behavioral assessments, brain imaging (MRI), and microscopic examination of brain tissue to measure improvements.

The results showed that mice receiving BYHWD had significantly better long-term recovery and less white matter damage. The researchers discovered that BYHWD works through specific biological mechanisms: it helps immune cells in the brain (called microglia) clean up damaged myelin (the protective coating around nerve fibers) and triggers these cells to release a growth factor called IGF1. This growth factor then stimulates the production of new cells that can create fresh myelin, essentially helping the brain repair its damaged communication networks.

For patients considering treatment options after stroke, this research suggests that BYHWD may offer benefits beyond standard care by actively promoting repair of damaged brain tissue rather than simply preventing further damage. While this study was conducted in animals and human trials would be needed to confirm these benefits, it provides scientific evidence for how this traditional formula might work at the cellular level. If you're interested in exploring traditional Chinese medicine approaches including herbal formulas as part of stroke recovery, consult with a qualified, licensed acupuncturist or Chinese medicine practitioner.

This preclinical study investigated Buyang Huanwu Decoction's (BYHWD) mechanisms in post-stroke white matter repair using a transient middle cerebral artery occlusion (tMCAO) mouse model. Researchers employed network pharmacology to identify therapeutic targets, followed by validation through immunofluorescence, Western blotting, MRI, and histological staining (LFB, H&E, cresyl violet). Sample sizes were not explicitly stated in the abstract.

Key findings demonstrated that BYHWD significantly improved neurological outcomes and reduced white matter injury through TREM2-dependent mechanisms. Specifically, BYHWD enhanced microglial phagocytosis of myelin debris via upregulation of phagocytic receptors (AXL, CD11c) and activated the TREM2-ERK1/2 signaling pathway. This activation promoted microglial IGF1 secretion, which subsequently stimulated oligodendrocyte proliferation and remyelination, as evidenced by increased IGF1R expression.

Clinical relevance: This study provides mechanistic insight into BYHWD's neuroprotective effects, specifically its ability to modulate microglia-oligodendrocyte interactions for white matter repair. These findings support BYHWD's therapeutic potential in stroke rehabilitation, particularly for patients with significant white matter injury, though human clinical trials are needed for translation.